BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34915728)

  • 1. PRDM16 Is a Compact Myocardium-Enriched Transcription Factor Required to Maintain Compact Myocardial Cardiomyocyte Identity in Left Ventricle.
    Wu T; Liang Z; Zhang Z; Liu C; Zhang L; Gu Y; Peterson KL; Evans SM; Fu XD; Chen J
    Circulation; 2022 Feb; 145(8):586-602. PubMed ID: 34915728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Missense Mutation in Human CHD4 Causes Ventricular Noncompaction by Repressing ADAMTS1.
    Shi W; Scialdone AP; Emerson JI; Mei L; Wasson LK; Davies HA; Seidman CE; Seidman JG; Cook JG; Conlon FL
    Circ Res; 2023 Jun; 133(1):48-67. PubMed ID: 37254794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonsense Variant PRDM16-Q187X Causes Impaired Myocardial Development and TGF-β Signaling Resulting in Noncompaction Cardiomyopathy in Humans and Mice.
    Sun B; Rouzbehani OMT; Kramer RJ; Ghosh R; Perelli RM; Atkins S; Fatahian AN; Davis K; Szulik MW; Goodman MA; Hathaway MA; Chi E; Word TA; Tunuguntla H; Denfield SW; Wehrens XHT; Whitehead KJ; Abdelnasser HY; Warren JS; Wu M; Franklin S; Boudina S; Landstrom AP
    Circ Heart Fail; 2023 Dec; 16(12):e010351. PubMed ID: 38113297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac-specific inactivation of
    Nam JM; Lim JE; Ha TW; Oh B; Kang JO
    Am J Physiol Heart Circ Physiol; 2020 Apr; 318(4):H764-H777. PubMed ID: 32083975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fine mapping of the 1p36 deletion syndrome identifies mutation of PRDM16 as a cause of cardiomyopathy.
    Arndt AK; Schafer S; Drenckhahn JD; Sabeh MK; Plovie ER; Caliebe A; Klopocki E; Musso G; Werdich AA; Kalwa H; Heinig M; Padera RF; Wassilew K; Bluhm J; Harnack C; Martitz J; Barton PJ; Greutmann M; Berger F; Hubner N; Siebert R; Kramer HH; Cook SA; MacRae CA; Klaassen S
    Am J Hum Genet; 2013 Jul; 93(1):67-77. PubMed ID: 23768516
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 14-3-3ε plays a role in cardiac ventricular compaction by regulating the cardiomyocyte cell cycle.
    Kosaka Y; Cieslik KA; Li L; Lezin G; Maguire CT; Saijoh Y; Toyo-oka K; Gambello MJ; Vatta M; Wynshaw-Boris A; Baldini A; Yost HJ; Brunelli L
    Mol Cell Biol; 2012 Dec; 32(24):5089-102. PubMed ID: 23071090
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PRDM16 exerts critical role in myocardial metabolism and energetics in type 2 diabetes induced cardiomyopathy.
    Hu T; Wu Q; Yao Q; Yu J; Jiang K; Wan Y; Tang Q
    Metabolism; 2023 Sep; 146():155658. PubMed ID: 37433344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defects in Trabecular Development Contribute to Left Ventricular Noncompaction.
    Choquet C; Kelly RG; Miquerol L
    Pediatr Cardiol; 2019 Oct; 40(7):1331-1338. PubMed ID: 31342111
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hand factor ablation causes defective left ventricular chamber development and compromised adult cardiac function.
    Vincentz JW; Toolan KP; Zhang W; Firulli AB
    PLoS Genet; 2017 Jul; 13(7):e1006922. PubMed ID: 28732025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thinning of compact layer and systolic dysfunction in isolated left ventricular non-compaction: A cardiac magnetic resonance study.
    De Lazzari M; Brunetti G; Frasson E; Zorzi A; Cipriani A; Migliore F; De Conti G; Motta R; Perazzolo Marra M; Corrado D
    Int J Cardiol; 2024 Feb; 397():131614. PubMed ID: 38016624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prdm16 mutation determines sex-specific cardiac metabolism and identifies two novel cardiac metabolic regulators.
    Kühnisch J; Theisen S; Dartsch J; Fritsche-Guenther R; Kirchner M; Obermayer B; Bauer A; Kahlert AK; Rothe M; Beule D; Heuser A; Mertins P; Kirwan JA; Berndt N; MacRae CA; Hubner N; Klaassen S
    Cardiovasc Res; 2024 Feb; 119(18):2902-2916. PubMed ID: 37842925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Human Hereditary Cardiomyopathy Shares a Genetic Substrate With Bicuspid Aortic Valve.
    Siguero-Álvarez M; Salguero-Jiménez A; Grego-Bessa J; de la Barrera J; MacGrogan D; Prados B; Sánchez-Sáez F; Piñeiro-Sabarís R; Felipe-Medina N; Torroja C; Gómez MJ; Sabater-Molina M; Escribá R; Richaud-Patin I; Iglesias-García O; Sbroggio M; Callejas S; O'Regan DP; McGurk KA; Dopazo A; Giovinazzo G; Ibañez B; Monserrat L; Pérez-Pomares JM; Sánchez-Cabo F; Pendas AM; Raya A; Gimeno-Blanes JR; de la Pompa JL
    Circulation; 2023 Jan; 147(1):47-65. PubMed ID: 36325906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy.
    Kodo K; Ong SG; Jahanbani F; Termglinchan V; Hirono K; InanlooRahatloo K; Ebert AD; Shukla P; Abilez OJ; Churko JM; Karakikes I; Jung G; Ichida F; Wu SM; Snyder MP; Bernstein D; Wu JC
    Nat Cell Biol; 2016 Oct; 18(10):1031-42. PubMed ID: 27642787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of left ventricular trabeculae using cardiovascular magnetic resonance for the diagnosis of left ventricular non-compaction: evaluation of trabecular volume and refined semi-quantitative criteria.
    Choi Y; Kim SM; Lee SC; Chang SA; Jang SY; Choe YH
    J Cardiovasc Magn Reson; 2016 May; 18(1):24. PubMed ID: 27142637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-Term Prognostic Value of Cardiac Magnetic Resonance in Left Ventricle Noncompaction: A Prospective Multicenter Study.
    Andreini D; Pontone G; Bogaert J; Roghi A; Barison A; Schwitter J; Mushtaq S; Vovas G; Sormani P; Aquaro GD; Monney P; Segurini C; Guglielmo M; Conte E; Fusini L; Dello Russo A; Lombardi M; Gripari P; Baggiano A; Fiorentini C; Lombardi F; Bartorelli AL; Pepi M; Masci PG
    J Am Coll Cardiol; 2016 Nov; 68(20):2166-2181. PubMed ID: 27855806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential Common Pathogenic Pathways for the Left Ventricular Noncompaction Cardiomyopathy (LVNC).
    Liu Y; Chen H; Shou W
    Pediatr Cardiol; 2018 Aug; 39(6):1099-1106. PubMed ID: 29766225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CHF1/Hey2 plays a pivotal role in left ventricular maturation through suppression of ectopic atrial gene expression.
    Koibuchi N; Chin MT
    Circ Res; 2007 Mar; 100(6):850-5. PubMed ID: 17332425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nrg1 Regulates Cardiomyocyte Migration and Cell Cycle in Ventricular Development.
    Grego-Bessa J; Gómez-Apiñaniz P; Prados B; Gómez MJ; MacGrogan D; de la Pompa JL
    Circ Res; 2023 Nov; 133(11):927-943. PubMed ID: 37846569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zinc transporter Slc39a8 is essential for cardiac ventricular compaction.
    Lin W; Li D; Cheng L; Li L; Liu F; Hand NJ; Epstein JA; Rader DJ
    J Clin Invest; 2018 Feb; 128(2):826-833. PubMed ID: 29337306
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated myocardial SORBS2 and the underlying implications in left ventricular noncompaction cardiomyopathy.
    Li C; Liu F; Liu S; Pan H; Du H; Huang J; Xie Y; Li Y; Zhao R; Wei Y
    EBioMedicine; 2020 Mar; 53():102695. PubMed ID: 32143182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.